S&P 500
737.62
+0.83%
DOW
496.13
+0.04%
NASDAQ
711.23
+2.34%
Russell
284.17
+0.68%
VIX
36.10
+0.73%
FTSE
46.70
+0.93%
Nikkei
92.22
+1.35%
BTC
80,171.08
+0.27%
ETH
2,307.01
+0.78%
Gold
433.77
+0.48%
Oil
133.59
-1.02%
Silver
73.01
+1.97%
S&P 500
737.62
+0.83%
DOW
496.13
+0.04%
NASDAQ
711.23
+2.34%
Russell
284.17
+0.68%
VIX
36.10
+0.73%
FTSE
46.70
+0.93%
Nikkei
92.22
+1.35%
BTC
80,171.08
+0.27%
ETH
2,307.01
+0.78%
Gold
433.77
+0.48%
Oil
133.59
-1.02%
Silver
73.01
+1.97%
Stock
Ti
News
Markets
Stocks
Screener
Calendar
Watchlist
Loading...
Home
/
Stocks
/
RXRX
/
News
RXRX
NASDAQ · Biotechnology
Recursion Pharmaceuticals-A
Small-Cap Stocks
Penny Stocks
Biotech Stocks
Healthcare Stocks
$3.27
-0.16 (-4.66%)
☆ Watch
As of May 9, 1:29 AM ET ·
Overview
Earnings
Forecast
Financials
News
Peers
Technicals
RXRX News
1 articles
Recursion Pharma Co-Founder Gibson to Exit Board Ahead of Q1 Results
Recursion Pharmaceuticals founder Chris Gibson will leave the board at the June annual meeting. Q1 earnings due May 6; focus on cash, clinical progress, and AI platform.
Earnings
May 1
↑